MetaCap

Myriad Genetics (MYGN) Stock Chart

NASDAQ: MYGNHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

4.280.00 (0.00%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

MYGN technical summary

MYGN is trading 19.0% above its 50-day simple moving average of $3.60 and 9.2% below its 200-day average of $4.71. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 58.2, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $2.74 (Aug 3, 2026) to $8.59 (Oct 16, 2025); the current price sits 26% of the way from the low to the high. Annualized 30-day volatility is 62.7%. Based on the last session's high, low and close, the classic pivot point is $4.24, with first resistance at $4.36 and first support at $4.16.

These indicators describe past price behavior for Myriad Genetics; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
8.59 (Oct 16)
1Y low
2.74 (Aug 3)
Last close
4.28

MYGN price performance

1 week

-0.70%

1 month

+34.59%

3 months

-27.09%

6 months

-10.27%

Year to date

-30.41%

1 year

-43.16%

3 years

-70.56%

5 years

-86.52%

MYGN price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day4.35Price below4.33Price below
10-day4.28Price below4.25Price above
20-day4.06Price above4.07Price above
50-day3.60Price above4.00Price above
100-day4.29Price below4.26Price above
200-day4.71Price below4.87Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)4.56
Resistance 2 (R2)4.44
Resistance 1 (R1)4.36
Pivot point4.24
Support 1 (S1)4.16
Support 2 (S2)4.04
Support 3 (S3)3.96

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis